Drug treatment of the hypertensive diabetic.
Kendall
M J
MJ
Department of Pharmacology, Medical School, Birmingham, UK.
Lewis
H
H
Griffith
M
M
Barnett
A H
AH
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use; D048909:Diabetes Complications; D004232:Diuretics; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors